ATE237303T1 - Verwendung von zusammensetzungen mit benzoylperoxyd, glycolsäure und zink zur behandlung von dermatologischen krankheiten - Google Patents

Verwendung von zusammensetzungen mit benzoylperoxyd, glycolsäure und zink zur behandlung von dermatologischen krankheiten

Info

Publication number
ATE237303T1
ATE237303T1 AT96930836T AT96930836T ATE237303T1 AT E237303 T1 ATE237303 T1 AT E237303T1 AT 96930836 T AT96930836 T AT 96930836T AT 96930836 T AT96930836 T AT 96930836T AT E237303 T1 ATE237303 T1 AT E237303T1
Authority
AT
Austria
Prior art keywords
zinc
treatment
compositions containing
glycolic acid
benzoyl peroxide
Prior art date
Application number
AT96930836T
Other languages
English (en)
Inventor
Eugene H Gans
Jonah Shacknai
Original Assignee
Medicis Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24192763&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE237303(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Medicis Pharmaceutical Corp filed Critical Medicis Pharmaceutical Corp
Application granted granted Critical
Publication of ATE237303T1 publication Critical patent/ATE237303T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/38—Percompounds, e.g. peracids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
AT96930836T 1995-10-27 1996-09-11 Verwendung von zusammensetzungen mit benzoylperoxyd, glycolsäure und zink zur behandlung von dermatologischen krankheiten ATE237303T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/549,374 US5648389A (en) 1995-10-27 1995-10-27 Compositions for the treatment of dermatological disorders and methods for their use
PCT/US1996/014617 WO1997015282A1 (en) 1995-10-27 1996-09-11 Compositions for the treatment of dermatological disorders and methods for their use

Publications (1)

Publication Number Publication Date
ATE237303T1 true ATE237303T1 (de) 2003-05-15

Family

ID=24192763

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96930836T ATE237303T1 (de) 1995-10-27 1996-09-11 Verwendung von zusammensetzungen mit benzoylperoxyd, glycolsäure und zink zur behandlung von dermatologischen krankheiten

Country Status (16)

Country Link
US (1) US5648389A (de)
EP (1) EP0800382B1 (de)
JP (1) JP3235731B2 (de)
AR (1) AR004016A1 (de)
AT (1) ATE237303T1 (de)
AU (1) AU6974996A (de)
CA (1) CA2209188C (de)
CZ (1) CZ9702003A3 (de)
DE (2) DE800382T1 (de)
ES (1) ES2116252T3 (de)
GR (1) GR980300033T1 (de)
HU (1) HUP9800033A3 (de)
IL (1) IL121170A (de)
NO (1) NO312613B1 (de)
RU (1) RU2134568C1 (de)
WO (1) WO1997015282A1 (de)

Families Citing this family (89)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9510162D0 (en) * 1995-05-19 1995-07-12 Bouras Elias Compositions for the treatment of skin conditions
US6010711A (en) * 1996-01-26 2000-01-04 University Of Rochester Methods, articles and compositions for the pharmacologic inhibition of bone resorption with phosphodiesterase inhibitors
US5908867A (en) * 1996-07-18 1999-06-01 Henry; James P. Reduction of hair growth
JP2001510773A (ja) * 1997-07-28 2001-08-07 ダーマトレイザー テクノロジーズ リミテッド 光線療法に基づく病原体の治療方法及びそれを達成するための組成物
GB9723669D0 (en) * 1997-11-07 1998-01-07 Univ Aberdeen Skin penetration enhancing components
US5994403A (en) * 1997-12-17 1999-11-30 Donatiello; Steven T. Tannin (tannic acid) treatment of athlete's foot and other fungal infections
US5912255A (en) * 1998-02-27 1999-06-15 Bussell; Letantia Topical fluoroquinolone antibiotics combined with benzoyl peroxide
US6017912A (en) * 1998-02-27 2000-01-25 Bussell; Letantia Topical fluoroquinolone antibiotics in an alcohol and acetone vehicle
FR2780888B1 (fr) * 1998-07-09 2000-10-13 Benac Lotion nettoyante et traitante destinee au traitement des comedons
US6497893B1 (en) * 1999-06-30 2002-12-24 Kimberly-Clark Worldwide, Inc. Silk protein treatment composition and treated substrate for transfer to skin
US6680073B1 (en) * 1999-04-08 2004-01-20 Bryon J. Tarbet Composition and method for the treatment of onychomycosis in animals
US6352691B1 (en) 1999-05-12 2002-03-05 Robert Ortiz Therapeutic after-shave care lotion
US6500443B1 (en) 1999-06-30 2002-12-31 Kimberly-Clark Worldwide, Inc. Delivery of a sacrificial substrate to inhibit protease permeation into skin
US6506394B1 (en) 1999-06-30 2003-01-14 Kimberly-Clark Worldwide, Inc. Delivery of a botanical extract to a treated substrate for transfer to skin
JP3503879B2 (ja) * 1999-07-07 2004-03-08 花王株式会社 化粧料
DE19938404A1 (de) 1999-08-13 2001-02-22 Clariant Gmbh Kosmetische Zubereitungen
AU2005202737B2 (en) * 1999-12-22 2009-01-22 Bayer Innovation Gmbh Use of chemotherapeutic agents
US6503524B1 (en) 2000-06-16 2003-01-07 Kimberly-Clark Worldwide, Inc. Delivery of a skin health benefit agent to a treated substrate for transfer to skin
US6630175B1 (en) 2000-06-29 2003-10-07 Johnson & Johnson Consumer Companies, Inc. Method of reducing eye irritation
US6432424B1 (en) 2000-06-29 2002-08-13 Johnson & Johnson Consumer Companies, Inc. Cosmetic compositions containing creatine, carnitine, and/or pyruvic acid
US6372791B1 (en) 2000-06-29 2002-04-16 Johnson & Johnson Consumer Companies, Inc. Method of promoting skin cell metabolism
US6649176B1 (en) 2000-06-29 2003-11-18 Johnson & Johnson Consumer Companies, Inc. Compositions containing mineral water
US6881731B1 (en) * 2000-10-23 2005-04-19 Shanbrom Technologies, Llc Enhancers for microbiological disinfection
GB0029018D0 (en) * 2000-11-28 2001-01-10 Strakan Group Plc Dermatological formulations
AT412448B (de) * 2001-02-13 2005-03-25 Vis Vitalis Lizenz & Handels Verwendung von selenhältigen präparaten
WO2002096374A2 (en) 2001-05-31 2002-12-05 Upsher-Smith Laboratories, Inc. Dermatological compositions and methods comprising alpha-hydroxy acids or derivatives
US6846846B2 (en) * 2001-10-23 2005-01-25 The Trustees Of Columbia University In The City Of New York Gentle-acting skin disinfectants
AT412703B (de) * 2001-12-04 2005-06-27 Vis Vitalis Lizenz & Handels Verwendung von selenithältigen präparaten zur topischen oder bukkalen anwendung
US20040029842A1 (en) * 2001-12-18 2004-02-12 Gardner Wallace J. Triglyceride lowering, common cold and pneumonia prevention composition comprising tetracycline, and methods of treating or preventing diseases using same
US7820186B2 (en) * 2001-12-21 2010-10-26 Galderma Research & Development Gel composition for once-daily treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt
US7745425B2 (en) * 2002-02-07 2010-06-29 The Trustees Of Columbia University In The City Of New York Non-irritating compositions containing zinc salts
EP1480517A4 (de) * 2002-02-07 2007-08-22 Univ Columbia Zinksalzzusammensetzungen für die vorbeugung von schleimhautreizung durch spermizide und mikrobizide
US7879365B2 (en) * 2002-02-07 2011-02-01 The Trustees Of Columbia University In The City Of New York Zinc salt compositions for the prevention of dermal and mucosal irritation
US6986896B2 (en) * 2002-03-20 2006-01-17 Bradley Pharmaceuticals, Inc. Method of treating fungal conditions of the skin
US20040043946A1 (en) * 2002-09-03 2004-03-04 Popp Karl F. Topical formulations for treatment of skin disorders
US20040171561A1 (en) * 2002-09-03 2004-09-02 Popp Karl F. Topical formulations for treatment of rosacea
US20040167223A1 (en) * 2002-09-03 2004-08-26 Popp Karl F. Topical antibacterial formulations
US7547454B2 (en) * 2002-11-07 2009-06-16 Shyam K Gupta Hydroxy acid complexes for antiaging and skin renovation
US20040156870A1 (en) * 2003-02-11 2004-08-12 Bradley Pharmaceuticals, Inc. Use of urea as a method for improving the effectiveness of topical anti-inflammatory drugs
US20040220259A1 (en) * 2003-04-04 2004-11-04 Yu Ruey J. Topical treatment of dermatological disorders associated with reactive or dilated blood vessels
US8734421B2 (en) 2003-06-30 2014-05-27 Johnson & Johnson Consumer Companies, Inc. Methods of treating pores on the skin with electricity
US20050025817A1 (en) * 2003-07-03 2005-02-03 Bhatia Kuljit S. Delivery system for topical medications
US7776355B2 (en) * 2003-07-03 2010-08-17 Medics Pharmaceutical Corporation Delivery system for topical medications
US7871649B2 (en) * 2003-07-17 2011-01-18 The Trustees Of Columbia University In The City Of New York Antimicrobial compositions containing synergistic combinations of quaternary ammonium compounds and essential oils and/or constituents thereof
US20070275093A1 (en) * 2003-10-20 2007-11-29 Pierard Gerald E Methods for Treating Non-Microbial Inflammatory Skin Conditioners
US8158138B1 (en) 2004-05-20 2012-04-17 Fougera Pharmaceuticals, Inc. Urea compositions and their methods of manufacture
US7479289B2 (en) * 2004-07-02 2009-01-20 Medicis Pharmaceutical Corporation Stable cleanser compositions containing sulfur
US7655682B2 (en) * 2004-07-02 2010-02-02 Medicis Pharmaceutical Corporation Triple anti-irritant composition
US20060008537A1 (en) * 2004-07-07 2006-01-12 Wu Jeffrey M Method of treating acne
US20060008538A1 (en) * 2004-07-07 2006-01-12 Wu Jeffrey M Methods of treating the skin
AU2011242139B2 (en) * 2004-07-07 2012-08-16 Johnson & Johnson Consumer Inc. Compositions containing anti-acne agents and the use thereof
CA2590136A1 (en) 2004-12-10 2006-06-15 Talima Therapeutics, Inc. Compositions and methods for treating conditions of the nail unit
US20060275230A1 (en) 2004-12-10 2006-12-07 Frank Kochinke Compositions and methods for treating conditions of the nail unit
US8277495B2 (en) 2005-01-13 2012-10-02 Candela Corporation Method and apparatus for treating a diseased nail
US20060172982A1 (en) * 2005-01-28 2006-08-03 Gardner Wallace J Formulation comprising tetracycline or derivative and method of treating or preventing infections and inflammatory conditions
US20090076132A1 (en) * 2005-03-11 2009-03-19 Gary Pekoe Antiviral compositions and methods of treatment
US20080166426A1 (en) * 2005-03-11 2008-07-10 Gary Pekoe Anitbacterial compositions and methods of treatment
FR2886851B1 (fr) * 2005-06-10 2007-10-05 Galderma Sa Composition a base d'une avermectine et de metronidazole notamment pour le traitement de la rosacee
US20070071705A1 (en) * 2005-09-29 2007-03-29 De Oliveira Monica A M Topical anti-microbial compositions
US7670629B2 (en) * 2005-12-21 2010-03-02 Robert Baltzell Method of treating bacterial hoof infections of sheep and cattle
US7759327B2 (en) * 2006-01-06 2010-07-20 The Trustees Of Columbia University In The City Of New York Compositions containing zinc salts for coating medical articles
CA2645073A1 (en) * 2006-03-08 2007-09-13 Nuviance, Inc. Transdermal drug delivery compositions and topical compositions for application on the skin
KR101368107B1 (ko) 2006-03-31 2014-03-14 스티펠 리서치 오스트레일리아 피티와이 리미티드 발포성 현탁겔
GB0617191D0 (en) * 2006-08-31 2006-10-11 York Pharma Plc Improvements in pharmaceutical compositions
US20080113037A1 (en) * 2006-11-10 2008-05-15 Green Barbara A Topical Compositions Comprising Polyhydroxy Acids and/or Lactones for Improved Cutaneous Effects of Oxidative Therapeutic Drugs
US20080206359A1 (en) * 2007-02-23 2008-08-28 Nikita Wilson Day and Night Composition and method for treating Pseudofolliculitis Barbae
CA2682375A1 (en) * 2007-03-30 2008-10-09 Suntory Holdings Limited Medicinal composition, food or drink having effect of enhancing parasympathetic nervous activity
US20090137534A1 (en) * 2007-11-26 2009-05-28 Chaudhuri Ratan K Skin treatment compositions and methods
US20080287373A1 (en) * 2007-05-17 2008-11-20 Popp Karl F Topical skin treating kits
US20110076261A1 (en) * 2007-06-19 2011-03-31 Bhiku Patel Antifungal Drug Delivery System
US20110082118A1 (en) * 2007-06-19 2011-04-07 Bhiku Patel Onychomycosis Treatment Delivery System
WO2008156798A1 (en) * 2007-06-19 2008-12-24 Prugen, Inc. Drug combination for the treatment of skin disorders
GB0715141D0 (en) * 2007-08-03 2007-09-12 York Pharma Plc Improving skin barrier function
BRPI0910998A2 (pt) * 2008-07-17 2016-01-19 Georgia Levis composição para tratamento de acne e método para tratar acne
US20100226948A1 (en) * 2009-03-05 2010-09-09 Medicis Pharmaceutical Corporation Methods and compositions for treating acne
US20120089232A1 (en) 2009-03-27 2012-04-12 Jennifer Hagyoung Kang Choi Medical devices with galvanic particulates
JP5740393B2 (ja) * 2009-05-15 2015-06-24 バイオセプタ コーポレイションｂｉｏＣＥＰＴＡ Ｃｏｒｐｏｒａｔｉｏｎ 皮膚および爪の真菌感染症の局所治療に適した組成物
US20110070174A1 (en) * 2009-09-21 2011-03-24 PruGen IP Holdings, Inc. Benzoyl Peroxide and Sunscreen Agent Combination
US20110082216A1 (en) * 2009-10-02 2011-04-07 Wu Jeffrey M Benzoyl peroxide composition for treating skin
WO2012069061A2 (en) 2010-11-25 2012-05-31 Nrn Finance Aps A shaving composition for pseudofolliculitis barbae treatment
JP2016514024A (ja) 2013-03-14 2016-05-19 ハラックス，インコーポレイテッド 爪部の感染症、疾患または障害の治療方法
US9301935B2 (en) 2013-06-10 2016-04-05 Naeem Uddin Broad spectrum pharmacological composition for treatment of various infections and diseases and methods of use
US11110072B2 (en) 2013-06-10 2021-09-07 Greyfer Innova Pharma, Llc Broad spectrum pharmacological composition for treatment of various infections and diseases and methods of use
US10493050B2 (en) 2013-06-10 2019-12-03 Naeem Uddin Broad spectrum pharmacological composition for treatmentof various infections and diseases and methodsof use
US10646461B2 (en) 2013-06-10 2020-05-12 Naeem Uddin Broad spectrum pharmacological composition for treatment of various infections and diseases and methods of use
US10716305B2 (en) 2015-01-23 2020-07-21 Biocidium Biopharmaceuticals Inc. Anti-bacterial compositions
US11065223B2 (en) 2016-02-22 2021-07-20 Board Of Regents, The University Of Texas System Antimicrobial compositions and uses thereof
US11559053B1 (en) 2016-09-23 2023-01-24 Specialty Sales, LLC Livestock footbath solutions and methods of use
EP3801455A1 (de) * 2018-05-30 2021-04-14 Eviderm Institute AB Milde zusammensetzung zur verwendung in der topischen behandlung von durch einen virus und pilz verursachten haut- und nagelerkrankungen

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4363815A (en) * 1975-07-23 1982-12-14 Yu Ruey J Alpha hydroxyacids, alpha ketoacids and their use in treating skin conditions
US4514385A (en) * 1981-10-05 1985-04-30 Alcon Laboratories, Inc. Anti-acne compositions
JPS58134009A (ja) * 1982-02-02 1983-08-10 ユニリ−バ−・ナ−ムロ−ゼ・ベンノ−トシヤ−プ 皮膚処理用組成物
AU548341B2 (en) * 1982-02-02 1985-12-05 Unilever Plc Acne treatment composition
US4895727A (en) * 1985-05-03 1990-01-23 Chemex Pharmaceuticals, Inc. Pharmaceutical vehicles for exhancing penetration and retention in the skin
US5385938B1 (en) * 1986-12-23 1997-07-15 Tristrata Inc Method of using glycolic acid for treating wrinkles
US5091171B2 (en) * 1986-12-23 1997-07-15 Tristrata Inc Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use
DE3704214A1 (de) * 1987-02-11 1988-08-25 Haide Dr Med Wachtl Aknesalbe
AU609090B2 (en) * 1987-02-18 1991-04-26 Milor Scientific, Ltd. Composition for treatment of acne
US5258391A (en) * 1987-05-15 1993-11-02 Scott Eugene J Van Phenyl alpha acyloxyalkanoic acids, derivatives and their therapeutic use
AU619256B2 (en) * 1988-03-03 1992-01-23 Connetics Australia Pty Ltd Acne treatment
NL8900165A (nl) * 1989-01-24 1990-08-16 Matthijs Cornelis Evers Wondpoeder.
GB9010525D0 (en) * 1990-05-10 1990-07-04 Unilever Plc Cosmetic composition
ES2061407B1 (es) * 1993-05-17 1995-06-16 Cid Carlos Arturo Castilla Producto en forma de champu antifungico y antibacteriano de rapida accion.
FR2714602B1 (fr) * 1993-12-30 1996-02-09 Oreal Composition antiacnéique pour le traitement simultané des couches superficielles et profondes de la peau, son utilisation.
KR970701531A (ko) * 1994-03-03 1997-04-12 레이서 제이코버스 코넬리스 항-여드름 조성물(anti-acne compositions)
FR2718022B1 (fr) * 1994-04-01 1996-04-26 Roussel Uclaf Compositions cosmétiques ou dermatologiques et leur préparation.

Also Published As

Publication number Publication date
CA2209188C (en) 2002-01-22
AR004016A1 (es) 1998-09-30
HUP9800033A3 (en) 2001-04-28
DE69627467D1 (de) 2003-05-22
IL121170A (en) 2004-08-31
US5648389A (en) 1997-07-15
ES2116252T3 (es) 2003-10-16
ES2116252T1 (es) 1998-07-16
NO312613B1 (no) 2002-06-10
WO1997015282A1 (en) 1997-05-01
HUP9800033A2 (hu) 1998-06-29
CZ9702003A3 (en) 1997-11-12
MX9704820A (es) 1998-07-31
AU6974996A (en) 1997-05-15
RU2134568C1 (ru) 1999-08-20
NO972972L (no) 1997-08-21
JPH10502944A (ja) 1998-03-17
CA2209188A1 (en) 1997-05-01
NO972972D0 (no) 1997-06-25
IL121170A0 (en) 1997-11-20
JP3235731B2 (ja) 2001-12-04
EP0800382A1 (de) 1997-10-15
DE69627467T2 (de) 2004-01-15
EP0800382B1 (de) 2003-04-16
GR980300033T1 (en) 1998-07-31
DE800382T1 (de) 1998-08-13

Similar Documents

Publication Publication Date Title
ATE237303T1 (de) Verwendung von zusammensetzungen mit benzoylperoxyd, glycolsäure und zink zur behandlung von dermatologischen krankheiten
DE69836752D1 (de) Prostaglandinagoniste und deren verwendung zur behandlung von knochenerkrankungen
DE68923819T2 (de) Verwendung von gamma-Hydroxy-Buttersäuresalzen zur Herstellung von pharmazeutischen Zusammensetzungen zur Verwendung bei der Behandlung von Alkoholismus und die hergestellten Zusammensetzungen.
DE69918687D1 (de) 4-phenylpiperidine zur behandlung von prutitischen hauterkrankungen
ATE252901T1 (de) Arzneimittel zur behandlung von entzündlichen herzkrankheiten
DE69821667D1 (de) Kardioverter zur Behandlung von Vorhofflattern
DE69626539D1 (de) topische Verwendung von Vitamin D zur Behandlung von Augenerkrankungen
DE69824576D1 (de) Verwendung von tetrahydropyridinderivaten zur herstellung von arzneimitteln zur behandlung demyelinisierender erkrankungen
DE69501105T2 (de) L-Carnitin-Salz, dieses enthaltende kosmetische und pharmazeutische Zusammensetzungen zur Behandlung von Dermatosen
ATE221763T1 (de) Die verwendung von glyceryltriacetat zur behandlung von onychomykosen
DE69420229T2 (de) Pharmazeutische Zusammensetzung zur Behandlung von AIDS
DE69932922D1 (de) Verwendung von alkansäuren-enthaltenden zusammensetzungen zur behandlung von nagelpilz-erkrankungen
DE69503724T2 (de) L-Carnitin-Salz, dieses enthaltende kosmetische und pharmazeutische Zusammensetzungen zur Behandlung von Dermatosen
DE69729735D1 (de) Verwendung von benzopyranolen zur behandlung von neurologischen erkrankungen
DE69822276T2 (de) Kräuter formulierung mit therapeutischer und kosmetischer verwendung zur behandlung von allgemeinen hauterkrankungen
CA2100720A1 (en) Medicinal composition comprising tcf-ii
DE69913380D1 (de) Zusammensetzung zur behandlung von periodontalen erkrankungen
DE3686019D1 (de) Die verwendung von nitrofurantoin zur behandlung und verhuetung von magen-darmkrankheiten.
DE19681032D2 (de) Gentherapeutisches Nukleinsäurekonstrukt, seine Herstellung und Verwendung zur Behandlung von Herzerkrankungen
DE69739190D1 (de) Arzneimittel zur behandlung von oculären kreislauferkrankungen
DE69813354D1 (de) Mittel zur Behandlung von Herzkrankheiten
DE69417724T2 (de) 5-Morpholinmethyl-3-(4-chlorbenzylidenamin)-2-oxazolidinon enthaltende pharmazeutische Zubereitung und ihre Verwendung zur Behandlung von Erkrankungen des ZNS
DE68914886D1 (de) Mittel zur Behandlung von Raynaud's Krankheit.
DE59609836D1 (de) Verwendung von zuckertensiden zur behandlung von ledern und pelzen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0800382

Country of ref document: EP

REN Ceased due to non-payment of the annual fee